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Aims The inflammatory response to injurious agents is tightly regulated to avoid adverse consequences of inappropriate
leucocyte accumulation or failed resolution. Lipopolysaccharide (LPS)-activated endothelium recruits leucocytes to
the inflamed tissue through controlled expression of membrane-associated adhesion molecules. LPS responses in
macrophages are known to be regulated by integrin-linked kinase (ILK); in this study, we investigated the role of
ILK in the regulation of the LPS-elicited inflammatory response in endothelium.
Methods
and results
This study was performed on immortalized mouse endothelial cells (EC) isolated from lung and coronary vasculature.
Cells were thoroughly characterized and the role of ILK in the regulation of the LPS response was investigated by sup-
pressing ILK expression using siRNA and shRNA technologies. Phenotypic and functional analyses confirmed that the
immortalized cells behaved as true EC. LPS induced the expression of the inflammatory genes E-selectin, intercellular
adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). ILK knockdown impaired LPS-
mediated endothelial activation by preventing the induction of ICAM-1 and VCAM-1. Blockade of the LPS-induced
response inhibited the inflammatory-related processes of firm adhesion and trans-endothelial migration of leucocytes.
Conclusion ILK is involved in the expression of cell adhesion molecules by EC activated with the inflammatory stimulus LPS. This
reduced expression modulates leucocyte adhesion to the endothelium and the extravasation process. This finding
suggests ILK as a potential anti-inflammatory target for the development of vascular-specific treatments for inflam-
mation-related diseases.
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1. Introduction
The development of new treatments for cardiovascular diseases requires
the identification of molecules that play specific roles in these pathol-
ogies. The endothelium forms a barrier between the vessel lumen and
the surrounding tissue and is critical for host immune responses during
inflammation and infection. When exposed to inflammatory mediators,
such as tumour necrosis factor-a (TNF-a) or lipopolysaccharide (LPS),
the quiescent endothelium becomes activated and expresses additional
pro-inflammatory factors and cell-specific adhesion molecules that
enable the extravasation of circulating leucocytes to sites of inflam-
mation. The initial step involves recruitment of leucocytes to the endo-
thelial surface through the binding of leucocyte-expressed L-selectin and
endothelium-expressed E- and P-selectins to carbohydrate moieties on
the contacting cell. Firm adhesion is mediated by intercellular adhesion
molecule-1 (ICAM-1) and vascular cell adhesion molecule-1
(VCAM-1) on the endothelium, which bind b2 and b1 integrins on leu-
cocytes, respectively.1–4 Excessive leucocyte accumulation contributes
to the development of inflammatory disorders, whereas a deficiency in
leucocyte trafficking results in host immunosuppression.
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An intermediary component of LPS signalling is integrin-linked kinase
(ILK), which mediates LPS-induced NOS-2 and COX-2 expression and
NO production in macrophages.5 ILK is a widely distributed pseudoki-
nase located in specialized signalling complexes called focal contacts,
and regulates signalling from integrins and growth factor receptors.
The ILK carboxyl terminal region contains a kinase-like domain, the
integrin-binding domain, and motifs for binding to the actin cytoskele-
ton via alpha and beta parvin adaptor proteins. The ILK amino terminus
binds to PINCH, which interacts with the adapter protein Nck2. Nck2
recruits actin regulatory proteins and can bind tyrosine phosphorylated
residues of activated growth factor receptors.6 The formation of the
ILK-PINCH-Parvin ternary complex is necessary for ILK function and
for its recruitment to focal contacts.7
The ability of ILK to integrate signals from integrins and growth factor
receptors suggests an involvement in many biological situations. Acti-
vation of ILK induces cell survival and cell proliferation,8,9 and ILK
closely regulates capillary formation and the survival of endothelial and
progenitor cells.10,11 The role of ILK in pathological processes has
been confirmed in several in vivo models, including cardiac repair,12 car-
diomyopathy,13,14 tumour angiogenesis,15 and skeletal muscle regener-
ation.16 ILK knockout models, both germline17 and conditional,16,18–20
have revealed essential roles in development and adult physiology. Endo-
thelial ILK appears to play a specific role in the development of the cor-
onary vasculature (A. Luque et al., in preparation) confirming the
variability of endothelial function between different organs.21
In this study, we investigated the role of ILK in the regulation of
LPS-elicited inflammatory responses in endothelial cells (EC). Using
immortalized EC lines of lung or coronary origin, we show that ILK
is required for LPS-induced endothelial expression of ICAM-1 and
VCAM-1. Moreover, LPS-stimulated EC lacking ILK show reduced
adhesion of primary lymphocytes and monocytic lines and impaired
trans-endothelial migration of lymphocytes. These results propose
ILK as a potential target for the design of vascular-specific treatments
for bacterial associated inflammation.
2. Methods
2.1 Animals and cell isolation
EC were isolated and maintained as described22 from whole lungs and
coronary vasculature of C57/BL6 wild-type animals and the genetically
modified ILK lox/lox strain.17,18 Spleen lymphocytes were isolated from
C57/BL6 wild-type animals (see Supplementary material online,
Methods). The study was approved by ‘Comite´ de Bioe´tica y Bienestar
Animal. Instituto de Salud Carlos III’ conformed to the Guide for the
Care and Use of Laboratory Animals published by the US National Insti-
tutes of Health (NIH Publication No. 85-23, revised 1996).
2.2 Positive endothelial selection with
antibody-bound magnetic beads
EC were isolated by positive selection using PECAM-1 or ICAM-2 anti-
bodies bound to magnetic beads (Dynabeadsw, Invitrogen) as described
previously.22 Cells were further purified by FACS (MoFlo, Beckman
Coulter) using standard procedures.
2.3 Immortalization of EC
EC lines were established using a modified version from previous
reports.22,23 Subconfluent primary cultures were incubated in the pres-
ence of polybrene (8 mg/mL, Sigma) with supernatant from packaging
cells producing recombinant retroviruses that transduced polyoma
middle T antigen (virus concentration about 10–200 pfu/cell). Cells
were subjected to a second round of infection. Non-infected cells died
within few passages. Table 1 summarizes specific procedures performed.
2.4 Flow cytometry
Flow cytometry was performed following standard protocols (see Sup-
plementary material online, Methods). As required, EC transfected with
siRNAs or shRNA were incubated with TNF-a (PeproTech), Poly I:C
(InvivoGen), or LPS (E. coli 0111:B4 LPS, InvivoGen). Concentrations
used are specified for each figure.
2.5 Immunofluorescence
Cell immunostaining was performed as described24 and analysed with a
Leica TCS SP5 Multiphoton Confocal microscope.
2.6 LDL uptake
Alexa Fluor 488 acetylated low-density lipoprotein (Ac-LDL, L-23380,
Molecular Probes) was incubated with EC following manufacturer’s rec-
ommendation and incorporation was evaluated by flow cytometry.
2.7 Western blotting
Endothelial activation and protein expression were monitored by standard
immunoblot analysis of downstream phosphorylated targets (see Sup-
plementary material online, Table S1).24 Bands were quantified with Quan-
tity One software (BioRad).
2.8 Wound healing assay
Denuded areas (‘wounds’) were made in endothelial monolayers by scrap-
ing with a plastic pipette tip. Plates were then washed and cells stimulated
with VEGF (500 ng/mL, Peprotech). Cell migration into the denudated
area was monitored by time-lapse photomicroscopy and quantified with
AxioVisionLE 4.1 software.
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Table 1 Timetable of procedures for the generation of immortalized endothelial lines
MCoEC-25 MLEC-04 MCoEC-31 MLEC-12
Mouse strain: C57/Bl6 C57/Bl6 C57/Bl6 ILKlox/lox-C57/Bl6
Process date: 25/04/2006 04/05/2006 31/05/2006 12/07/2006
03/05/06, ICAM-2 selection 09/05/06, PECAM-1 selection 01/06/06, first virus-infection 13/07/06, first virus-infection
08/05/06, first virus-infection 12/05/06, first virus infection 02/06/06, PECAM-1 select 17/07/06, PECAM-1 select
12/05/06, second virus-infection 16/05/06, second virus-infection 05/06/06, second virus-infection 24/07/06, second virus-infection
19/05/06, PECAM-1 selection 30/05/06, PECAM-1 FACS-sorting 14/07/06, PECAM-1 FACS-sorting 22/08/06, first PECAM-1 FACS-sorting
30/06/06, PECAM-1 FACS-sorting 03/10/06, second PECAM-1FACS-sorting
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2.9 ILK silencing
ILK expression was suppressed by two rounds of transient transfection
with ILK siRNA (Ambion) using Lipofectamine 2000 (Invitrogen). Alterna-
tively, ILK-silenced EC were generated by the transfection with shRNA
plasmids followed by neomycin selection of positively transfected cells
(KM05291N, SABiosciences).
2.10 Real-time pcr
Transcript expression of adhesion receptors was measured by the SyBr
Green method with an ABI Prism 7900 HT Sequence Detection system
(see Supplementary material online, Methods).25
2.11 Leucocyte-endothelium co-adhesion assay
Wild-type or ILK-deficient endothelial monolayers in 96 well plates were
stimulated with TNF-a, Poly I:C, or LPS for 6 h. EC were then washed
several times and CFSE-(10 mM/20 min C1157, Molecular probes)-
labelled mouse monocyte/macrophage J774 cells, human T cell line
Jurkat or spleen lymphocytes were added (125.000–250.000 cells/well).
After 1 h, wells were washed and fluorescently-labelled cells attached
were measured after detergent treatment with a spectrofluorometer
plate reader (485 nm/535 nm, Fluoroskan Ascent, Thermo Labsystems).
Alternatively, wells were fixed in 3% paraformaldehyde and evaluated
by fluorescence microscopy. Each condition was performed in triplicate
and adhesion was calculated as a percentage of the adhesion to fibronec-
tin (10 mg/mL, Sigma). Identification of adhesion molecules involved was
assessed by including blocking antibodies (see Supplementary material
online, Table S1).
2.12 Trans-endothelial migration
shRNA-ILK or shRNA-control transfected EC were cultured to con-
fluency on gelatin-coated polycarbonate filter inserts (5 mm pores,
Corning) and either left unstimulated or stimulated with LPS or TNF-a
for 6 h. After washing the wells, 3–5  105 CFSE-labelled splenocytes
in RPMI media/0.5% BSA were placed in the upper compartment and
allowed to migrate for 2 h towards SDF-1 (50 ng/mL, PeproTech)
placed in the lower chamber. Transmigrated lymphocytes were quantified
by microscopy. Migrated splenocytes were represented as the percentage
of the total cellular input. Assays were run in triplicate.
2.13 Statistical analysis
All data are means+ standard deviations of three independent exper-
iments. Statistical significance was estimated by Student’s t-test for
unpaired observations, with P, 0.05 considered significant. Analysis
was performed with the Prism 3 program (GraphPad Software).
3. Results
3.1 Generation and phenotypic description
of novel immortalized mouse EC
To examine the role of ILK in inflammatory response of different
vascular beds (A. Luque et al., in preparation), we isolated EC from
the mouse lung and coronary vasculatures. Since the number of EC
obtained, especially from coronary vessels, was insufficient for the
experimentation proposed, we generated immortalized cultures to
provide infinite biological material. Procedures for generating cell
lines included several rounds of endothelial positive selection and
two rounds of infection with the polyoma virus middle T (summarized
in Table 1).
Four cell lines were established: two mouse lung endothelial cell
(MLEC) cultures, MLEC-04 and MLEC-12; and two mouse coronary
endothelial cell (MCoEC) cultures, MCoEC-25 and MCoEC-31. The
identification numbers refer to the isolation date. MLEC-12 cells
were isolated from ILK lox/lox mice,17,18 although the other lines
were obtained from wild-type C57/BL6 mice.
Light field microscopy revealed the cobblestone monolayer mor-
phology typical of endothelial cultures (Figure 1A). In all immortalized
cell lines, flow cytometry detected expression patterns of the endo-
thelial markers PECAM-1, ICAM-1, and ICAM-2 similar to those
Figure 1 Generation and phenotypic description of novel immorta-
lized mouse EC. (A) Light field microscopy showing typical
cobblestone-like morphology of the four immortalized endothelial
lines: MCoEC-25, MCoEC-31, MLEC-04, and MLEC-12. Scale bar
equals 50 mm. (B) Flow cytometry analysis of the endothelial surface
markers PECAM-1, ICAM-1, ICAM-2, and VCAM-1 on the immorta-
lized EC lines and primary MLEC. Dark profiles corresponded to
expression of the selected antigen, isotype matched negative controls
are shown in white. (C) PECAM-1 and ZO-1 immunofluorescence
staining of confluent MLEC-04. Scale bar equals 10 mm.
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seen in primary MLEC. In contrast, only MCoEC-31 and MLEC-04
resembled primary EC regarding VCAM-1 levels (Figure 1B). Unless
otherwise stated, data shown in subsequent experiments for an indi-
vidual cell line are representative of similar results obtained with the
other immortalized EC lines.
Endothelial polarity and selective permeability depend on specific
intercellular connections.26 Immunocytochemical analysis of confluent
MLEC-04 confirmed localization of the endothelial homophilic
adhesion protein PECAM-1 at intercellular contacts and of the tight
junction molecule ZO-1 at the cell–cell boundaries along lateral
cell borders (Figure 1C).
3.2 Functional characterization of the
mouse endothelial lines
The usefulness of the immortalized cell lines as in vitro models of
endothelial processes was evaluated through a series of functional
assays. EC lines labelled with Alexa Fluor 488 Ac-LDL were brilliantly
fluorescent comparable to primary MLEC, indicating characteristic
high endothelial Ac-LDL uptake and metabolism;27 in contrast, fluor-
escence intensity of a murine keratinocyte cell line (PB) was only
slightly above background (Figure 2A). The four endothelial lines also
express the receptor tyrosine kinase VEGFR2 (Figures 2B and 3A),
which mediates most of the angiogenic actions of VEGF.28 Stimulation
of EC with VEGF induced VEGFR2 autophosphorylation, detected by
immunoblotting with the anti-phosphotyrosine antibody PY20 fol-
lowed by anti-VEGFR2 antibody. Sequential membrane reprobing
with phospho-specific antibodies detected VEGF-induced phos-
phorylation of Akt, GSK-3b, and ERK (Figure 2B). VEGF-stimulated
endothelial migration was evaluated in wound healing assays.29
Increased migration of EC in the presence of VEGF is evident from
the pronounced closure of the denuded region at 24 h compared
with control (Figure 2C).
The induced expression of adhesion molecules—essential for leu-
cocyte recruitment in response to inflammatory stimulation—was
tested by activating quiescent EC with LPS or TNF-a. Upon activation,
immortalized cultures overexpressed E-selectin, VCAM-1, and
ICAM-1 similarly as occurred in primary MLEC. As expected,
ICAM-2 and PECAM-1 expression was invariable under these con-
ditions (Figure 2D). Together these results confirm the immortalized
cultures as true EC, thus characterizing a useful resource for vascular
research.
3.3 Expression of the ILK signalosome by
EC lines and ILK down-regulation
The four endothelial lines expressed similar levels of ILK protein and
its adaptor proteins PINCH-1 and a- and b-parvin (Figure 3A),
suggesting normal signalling through ILK in these cell types.
The function of ILK in endothelial biology was evaluated by knock-
down approaches. ILK expression in all four EC lines was suppressed
with siRNA reagents. Approximately 65–75% of ILK protein was
eliminated after two rounds of transfection (Figure 3B). In addition,
we used shRNA reagents to generate stable ILK-deficient lines.
After shRNA-EC transfection and neomycin selection, ILK expression
was reduced to around 25% compared with the shRNA control
(Figure 3C). In another approach, MLEC-12 derived from ILK lox/lox
animals were positively tested for ILK elimination after cre enzyme
expression (Supplementary material online, Figure S1). However,
Figure 2 Functional characterization of mouse endothelial lines.
(A) AcLDL uptake. EC were incubated with Alexa Fluor
488-AcLDL (dark histograms) and examined by flow cytometry.
PB cells were used as control. (B) VEGF signalling. Resting (2) or
VEGF-stimulated (þ) MLEC-12 were analysed by western blot
with sequential antibody stripping and reprobing of the same mem-
brane. Protein levels are quantified below each blot as a fold-increase
relative to b-actin densities. (C) Wound healing assays. Left-hand
panels show light field images of scraped VEGF-stimulated or
control MCoEC-31 monolayers at 0 and 24 h. Scale bar equals
100 mm. Quantification (right panel) shows surface invaded ¼
a.u.(0 h)2 a.u.(24 h). (D) Inflammatory response of EC.
MCoEC-25, MLEC-04, and primary MLEC were left untreated
(white histograms) or stimulated (dark histograms) with LPS
(500 ng/mL) or TNF-a (15 ng/mL) for 6 h and expression of
surface adhesion molecules was assessed by flow cytometry.
‘Control’ shows isotype matched negative controls.
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since siRNA technology is applicable to all four EC lines and shRNA
EC show similar reductions in ILK expression, siRNA/shRNA
approaches were used in all subsequent experiments.
3.4 ILK regulates LPS-induced
transcription of ICAM-1 and VCAM-1 in EC
To test the role of endothelial ILK in LPS-induced responses, we first
analysed the effect of ILK knockdown on the expression of
inflammation-related genes. LPS stimulation of MLEC-04 increased
the transcription rate of E-selectin by three-fold, and ICAM-1 and
VCAM-1 by about 10- and 17-fold. Transfection with ILK-siRNA wea-
kened LPS-induced ICAM-1 and VCAM-1 expression to 60 and 20%
of the control values but did not affect LPS-induced expression of
E-selectin. ICAM2 was examined as a non-varying endothelial
marker (Figure 4A). We next evaluated ILK function in response to
different pro-inflammatory conditions. Increasing amounts of LPS
(10–500 ng/mL) induced ICAM-1 expression in a concentration-
dependent manner, and suppression of this expression in
ILK-siRNA-transfected MLEC-04 was significant at higher LPS concen-
trations (100 and 500 ng/mL). In contrast, ILK knockdown did not sig-
nificantly interfere with EC expression of ICAM-1 mRNA induced by
TNF-a or Poly I:C (Figure 4B and see Supplementary material online,
Figure S2).
3.5 LPS-induced VCAM-1 and ICAM-1
protein expression is partially inhibited
in ILK-deficient EC
Resting MCoEC-25 cells do not express VCAM-1 protein, shown by
flow cytometry (Figure 1B) and western blot (‘resting’ in Figure 5A).
LPS induced VCAM-1 protein expression on the cell surface
(Figure 2D), coinciding with increased amounts of VCAM-1 protein
in total cell lysates (‘LPS-C’ in Figure 5A). ILK knockdown significantly
inhibited the LPS-induced increase in VCAM-1 protein expression
(‘LPS-I’, Figure 5A, top panel) to about 50% of that in LPS-stimulated
controls (‘LPS-C’), as shown by densitometry analysis (‘L-ILK’ com-
pared with ‘L-4611’, Figure 5A, lower panel).
Non-stimulated MCoEC-25 cells express ICAM-1 (Figures 1B and
5B ‘resting’). This expression was increased by LPS (Figures 2D and
5B ‘LPS-C’), a response partially inhibited in ILK knockdown cells
(Figure 5B ‘LPS-I’); densitometry analysis revealed ICAM-1 protein
expression in LPS-treated knocked-down cells to be reduced 35%
of the value in LPS-stimulated controls (Figure 5B, lower panel).
Further flow cytometry analysis of MCoEC-25 (Figure 5C and D)
and MLEC-04 (data not shown) confirmed that the reduced
VCAM-1 and ICAM-1 expression in LPS-treated ILK-deficient EC cor-
relates with lower cell surface localization. In contrast, VCAM-1 and
ICAM-1 over-expression induced by TNF-a and Poly I:C was not
affected by the absence of endothelial ILK. ICAM-2 expression was
invariable under all conditions (data not shown).
3.6 Down-regulation of endothelial ILK
reduces the adhesion of leucocytes to
LPS-activated endothelium
ILK-mediated regulation of LPS-induced cell adhesion molecules
suggests a regulatory action for ILK on leucocyte adhesion to endo-
thelium, event that was investigated with functional co-adhesion
experiments. CFSE labelled J774 cells were added to resting or stimu-
lated siRNA transfected EC and cell attachment was evaluated by flu-
orescence microscopy (Figure 6A, left panel). LPS and TNF-a
treatments increased monocyte adhesion to MLEC-04 monolayers.
Although endothelial ILK knockdown did not affect co-adhesion
under TNF-a stimulation or resting conditions, it severely inhibited
LPS (500 ng/mL)-stimulated adhesion. As it was expected, no ILK
regulation occurred at 25 ng/mL because very low EC activation
was achieved in this condition (Figure 4B and data not shown). Parallel
experiments were quantified by spectrofluorometry of lysed cells
(Figure 6A, right panel).
To identify the molecule pairs involved in J774-endothelium
binding, first we tested adhesion molecules expressed by the mono-
cytic line. J774 cells express CD11a, CD11b, and CD11c associated
with integrin b2, which are receptors for ICAM-1, whereas CD49d
Figure 3 Expression of the ILK signalosome by EC lines and ILK
down-regulation approaches. (A) MLEC-04 (L04), MCoEC-25
(Co25), MCoEC-31 (Co31), and MLEC-12 (L12) express ILK and
the adaptor proteins PINCH1 and a- and b-parvins as shown
western blot of whole cell lysates. (B) Down-regulation of ILK by
siRNA. MCoEC-25 were subjected to two rounds of transfection
with ILK or control siRNA, and ILK levels were evaluated by
western blot. (C) MCoEC-25 and MLEC-04 transfected with
ILK-shRNA (I) reduced ILK protein expression compared with
control-shRNA (C). In all cases b-actin was assessed as loading
control and the protein levels are quantified below each blot as a
fold-increase relative to the correspondent b-actin densities.
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associated with b1 integrin, the receptor for VCAM-1. CD45 was
examined as leucocytic positive control (Figure 6B). Next we con-
ducted co-adhesion experiments in the presence of blocking anti-
bodies to adhesion components (see manufacturer’s datasheet,
Supplementary material online, Table S1). Anti-b2 integrin antibody
partially reduced adhesion of J774 cells to resting MLEC-04, and
severely reduced the adhesion to LPS-activated endothelium
(Figure 6C). Thus the main adhesive complex in this experimental
setting appears to be endothelial ICAM-1, upregulated in response
to LPS, and b2 integrins on J774 cells.
To mimic a more physiological situation, next we used mouse
spleen lymphocytes. Adhesion of CFSE-splenocytes to MCoEC-25
(shRNA-Con) was increased after LPS, Poly I:C, or TNF-a endothelial
activation. As before, endothelial ILK knockdown (shRNA-ILK) did
not affect co-adhesion involving resting EC or stimulated with Poly
I:C or TNF-a, but significantly inhibited LPS-stimulated adhesion
(Figure 6D). Similar results were obtained with Jurkat cells (see Sup-
plementary material online, Figure S3).
3.7 Endothelial ILK regulates extravasation
of lymphocytes through LPS-activated
endothelium
An effective inflammatory response involves leucocytes attachment to
activated endothelium and trans-endothelial migration to the inflamed
focus. We therefore next evaluated the role of endothelial ILK in
extravasation in transwell migration assays.
shRNA transfected MCoEC-25 (control and ILK) were cultured to
confluence on polycarbonate filter and either left unstimulated or
stimulated with LPS or TNF-a. After washing the wells,
CFSE-splenocytes were placed in the upper compartment and
allowed to migrate towards SDF-1 gradient. LPS and TNF-a treat-
ments increased lymphocyte trans-endothelial migration, and
Figure 4 ILK regulates LPS-induced transcription of ICAM-1 and VCAM-1 in EC. (A) MLEC-04 transfected with ILK siRNA or control siRNA (4611)
were stimulated with LPS (500 ng/mL) for 6 h and expression of selected genes was evaluated by Real-Time PCR. r, resting cells; L, LPS-stimulated
cells. (B) MLEC-04 transfected with ILK (I) or control (C) siRNAs were incubated with indicated stimuli for 6 h and expression of ICAM-1 gene was
evaluated as before. Data are means+ SEM of three independent experiments conducted in triplicate. **P, 0.01 with respect to the control
condition.
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whereas endothelial ILK knockdown did not affect extravasation
across TNF-a stimulated or resting EC, it significantly inhibited
LPS-stimulated trans-endothelial migration (Figure 6E).
4. Discussion
EC play a critical role in regulating inflammation through their capacity
to direct leucocyte traffic via the controlled expression of homeo-
static and inflammatory mediators.1 A consequence of the stepwise
procedure of leucocyte recruitment is that blockade of any step will
interrupt the extravasation process and prevent leucocytes entering
the surrounding tissue. Therefore, anti-inflammatory strategies to
inhibit the function of cell adhesion molecules involved in
leucocyte-endothelium interaction are a promising means of regulat-
ing the cellular response in inflammation. Our results show that ILK
regulates the inflammatory reaction triggered by LPS in four new
mouse immortalized EC lines. These EC express ILK and the
co-adaptor molecules PINCH and parvin, suggesting normal ILK sig-
nalling. LPS induced transcription of the inflammatory genes
E-selectin, ICAM-1, and VCAM-1. LPS signals through ILK, as shown
by down-regulation of ICAM-1 and VCAM-1 expression in
LPS-activated ILK-deficient cells. Moreover, suppression of adhesion
molecule expression impaired both the adhesion of monocytic cells
and lymphocytes to LPS-activated endothelium and subsequent trans-
endothelial migration. In our system, ILK seems to specifically regulate
LPS-triggered EC activation, since the endothelial responses induced
by TNF-a or Poly I:C were unaffected. This finding is particularly rel-
evant because endothelial TLR4, the LPS receptor, has been identified
as the primary intravascular bacterial sensor, being entirely sufficient
to recruit neutrophils to peripheral tissues.30 These findings thus
identify a novel regulatory function of endothelial ILK in LPS-induced
leucocyte recruitment, suggesting ILK as a potential target for thera-
peutic modulation of inflammatory disorders triggered by infection
with Gram-negative bacteria.
We compared EC cultures derived from lung and coronary circula-
tion because our unpublished results with conditional knockouts indi-
cate that ILK makes a distinct contribution to the endothelium of
coronary vessels during development (A. Luque et al., in preparation).
However, the experiments presented here revealed no differences
between adult vascular beds in the ILK-mediated regulation of LPS
triggered responses. Nonetheless, all four endothelial lines were com-
parable to freshly isolated EC for a range of endothelial phenotypes,
as listed in the Supplementary material online, Table S2, positively
identifying them as true EC.31 In addition to data presented in this
Figure 5 LPS-induced VCAM-1 and ICAM-1 protein expression is partially inhibited in ILK-deficient EC. (A, B) MCoEC-25 transfected with ILK
siRNA (I, ILK) or control siRNA (C, 4611) were left resting (r) or treated with LPS (L, 500 ng/mL) for 6 h. The representative western blots
show expression of VCAM-1 (A) and ICAM-1 (B), with b-actin detected as a loading control. The histograms show semi-quantification of relative
band densities from four experiments. (C, D) Flow cytometry profiles of VCAM-1 and ICAM-1 on ILK-silenced (I) or control (C) shRNA transfected
MCoEC-25 on resting conditions or stimulated for 6 h with LPS (100 and 500 ng/mL), Poly I:C (30 mg/mL), or TNF-a (15 ng/mL). Data are the mean
fluorescence intensities of a representative experiment of three performed.
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study, all four cultures express endothelial NOS constitutively and
NOS-2 upon LPS activation (Supplementary material online, Figure S4).
These well-defined EC lines provide homogeneous cell systems for
the reproducible study of physiological and pathological processes
including inflammation, vascular tone, blood coagulation, angiogenesis,
haemostasis, and transport across blood vessels.
Crosstalk between ILK and FAK signalling has recently been
described in the regulation of vascular smooth muscle cells and
cardiac maintenance.13,32 FAK regulates ICAM-1 expression upon
b1 integrin adhesion, influencing cell viability and maturation.33
Another focal contact protein, Pyk2, mediates up-regulation of
LPS-induced VCAM-1 in smooth muscle cells.34 The fact that ILK
knockdown did not fully block ICAM-1 and VCAM-1 up-regulation
in LPS-treated EC might indicate the activity of compensatory mech-
anisms arising from crosstalk among different pathways located at the
focal contact area, a phenomenon that remains to be investigated.
Another possible explanation for the incomplete suppression of
LPS-induced adhesion molecule expression includes the deficient
elimination of ILK protein with the knockdown strategies used. The
remnant 25–35% ILK protein expression might reflect limited effi-
ciency of the reagents used or the long half life of the protein.35
The use of ILK knockout cells was not considered because they
have low survival and proliferation rates.17– 19 Cell counts indicate
that cell proliferation and survival in our immortalized cell cultures
Figure 6 Down-regulation of endothelial ILK reduces adhesion and extravasation of lymphocytes and monocytes to LPS-activated endothelium. (A)
Left panels: Fluorescence microscopy showing CFSE-J774 cells attached to resting or activated MLEC-04 cells transfected with control or ILK siRNA;
EC were activated before co-attachment for 6 h with LPS (25, 500 ng/mL) or TNF-a (15 ng/mL). Scale bar, 50 mm. Right panel: Spectrophotometric
quantification of CFSE-J774 fluorescence in parallel experiments. Results are the means+ SEM of four experiments. (B) Summary of cell adhesion
molecule expression on J774 cells analysed by flow cytometry. ‘%’, percentage of positive cells; ‘Mean’, mean fluorescence intensity. Control indicates
to isotype matched negative controls. (C) CFSE-J774 cells were incubated with resting or LPS-treated MLEC-04 in the absence (control, solid bars) or
presence of integrin b2 subunit blocking antibody (anti-beta2, clear bars). Results are the means+ SEM of three experiments. (D) Quantification of
the fluorescence signal from CFSE-spleen lymphocytes adhered to resting, LPS (500 ng/mL), Poly I:C (30 mg/mL), or TNF-a (15 ng/mL)-activated
MCoEC-25 expressing control-shRNA (solid bars) or ILK-shRNA (clear bars). Results are the means+ SEM of three experiments. (E) Splenocyte
trans-migration towards SDF-1 across control (C) or ILK (I) shRNA-transfected MCoEC-25 monolayers resting or previously activated with LPS
(100, 500 ng/mL) or TNF-a (15 ng/mL). Results are the means+ SEM of three experiments. *P, 0.05 and **P, 0.01 with respect to the control.
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were not affected by ILK-siRNA transfection or ILK-shRNA
expression (data not shown). Another possibility is that only part of
the signalling triggered by LPS in EC is dependent on ILK: the moder-
ate effect of ILK suppression on adhesion molecule expression might
reflect complexity of LPS-induced signalling, involving several path-
ways (ERK, JNK, p38, PI3K/Akt, and NF-kB).2
Several EC responses to LPS in vitro are similar to events occurring
during sepsis, including the production of pro-inflammatory cytokines
and the increased surface expression of E-selectin, ICAM-1, and
VCAM-1.3,4 Co-adhesion experiments are a widely used in vitro
model for studying the regulation of interactions between lymphoid
cells and the endothelial layer.34,36,37 The invariable attachment in
the presence of conditioned media derived from LPS-activated EC
(data not shown) did not motivate us to analyse the regulation of
endothelial cytokine production by ILK in this system.
The regulation of LPS-induced ICAM-1 and VCAM-1 overexpres-
sion by ILK, but not of E-selectin, suggests a role for ILK in firm
adhesion of lymphoid cells to the inflamed endothelium, whereas
rolling of circulating cells would be unaffected. Co-adhesion assays
in the presence of blocking antibodies revealed that of the molecules
tested only b2 integrins mediate J774 attachment to endothelium.
Nonetheless, the incomplete suppression of adhesion suggests that
other adhesion couples are involved in this process.
To our knowledge, this study provides the first description of the
involvement of ILK in the endothelial expression of cell adhesion mol-
ecules in response to LPS. The impact of ILK suppression on lymphoid
adhesion and subsequent transmigration suggests that vascular ILK
could be targeted to moderate the inflammatory response, possibly
improving the prognosis of LPS-mediated inflammatory diseases. A
previous report showed the involvement of ILK in the expression
of SDF-1 and ICAM-1 in EC in hypoxia.11 ILK also regulates the
expression of various endothelial markers in an extracellular matrix
dependent manner.37 Targeting of ILK has been proposed as a poten-
tial anti-cancer approach because of its role in proliferation, migration,
and survival of tumour cells.38 The identification of an additional anti-
adhesive potential for agents that target ILK suggests further appli-
cations in the treatment of inflammatory disorders. Several clinical
trials targeting cell adhesion molecules are in progress, based on
the ability of agents such as pharmacological drugs, antibodies, antag-
onist peptides, and antisense nucleotides to reduce injury in animal
models of inflammatory and immune disease.39 However, in some
cases systemic treatment with these agents has shown no therapeutic
effect or has adverse outcome. There is therefore a need to redirect
strategies to target the cells specifically involved in the disease. Much
work has been done to map different endothelium niches,40 but
further research is needed to identify the specific markers expressed
during pathological events.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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